Effect of noninvasive neuromodulation in the menopusal period in women

Cover Page


Cite item

Full Text

Abstract

In women with extragenital pathology in the menopausal period, the use of noninvasive neuromodulation for the treatment of psychovegetative disorders has been proposed. The method allows to reduce the severity of menopausal and psychosomatic (depression, anxiety) disorders and the level of their mutual influence.

About the authors

Aleksey Alekseevich Voropaev

National Medical Research Center for Rehabilitation and Balneology

Author for correspondence.
Email: woropaew@ya.ru

MD, PhD, senior researcher, National Medical Research Center for Rehabilitation and Balneology

Russian Federation, Moscow

A. Kh. Gaidarova

National Medical Research Center for Rehabilitation and Balneology

Email: woropaew@ya.ru
Russian Federation, Moscow

N. V. Kotenko

National Medical Research Center for Rehabilitation and Balneology

Email: woropaew@ya.ru
Russian Federation, Moscow

A. P. Rachin

National Medical Research Center for Rehabilitation and Balneology

Email: woropaew@ya.ru
Russian Federation, Moscow

N. G. Badalov

National Medical Research Center for Rehabilitation and Balneology

Email: woropaew@ya.ru
Russian Federation, Moscow

References

  1. Balan V.E. Urogenital disorders in menopause (clinic, diagnosis, replacement therapy: dis doct. med. sci. Moscow, 1998. 253 p. (In Russ.)
  2. Voropaev A.A., Gerasimenko M.Yu., Rachin A.P. Application of transcranial electrostimulation in patients with depressive anxiety disorders. Fizioterapiya, Bal’neologiya i Reabilitatsiya (Russian Journal of the Physical Therapy, Balneotherapy and Rehabilitation). 2016; 1(5): 244. (In Russ.)
  3. Zaidiyev Ya.Z. Hormone prevention and correction of systemic disorders in women in perimenopause: dis. Dr. med. sci. Moscow, 1997. 279 p. (In Russ.)
  4. Zaidieva Ya.Z. New treatment options for menopausal disorders in postmenopausal women. Ginekologiya. 2003; 5(1): 10–5. (In Russ.)
  5. Smetnik V.P. Clinical aspects of menopausal disorders. In: Proceedings of the conference «Hormonal therapy of menopausal disorders». Moscow, 1994: 4–8. (In Russ.)
  6. Crook D., Godsland I.F., Hull J. Hormone replacement therapy with dydrogesterone and 17β-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 months follow up. Br. J. Obstet. Gynecol. 1997; 104: 298–304.
  7. Ducker, E.M., Kopansky, L., Jarry, H., Wuttke, W. Effect of extracts from Cimicifuga racemoza on rats. Planta Medica. 1991; 57: 420–4.
  8. Siddle N., Jesinger D.K., Whitehead M.I. et al. Lipoproteins of postmenopausal estrogen therapy with added dydrogesterone. Br. J. Obstet. Gynaecol. 1990; 97: 1093-1100.
  9. Thorp J.M.Jr., Gavin N.J., Ohsfeldt R.L. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users. Am. J. Obstet. Gynecol. 2001; 185(2): 318–26.
  10. Jarry H., Harnischfeger G., Dücker E. Studies on the endocrine effects of the contents of Cimicifuga racemosa 2. In vitro binding of compounds to estrogen receptors. Planta Medica. 1985; 51(4): 316–9.
  11. Lohnung A., Verspohl E.J., Winterhoff H. Pharmacological studies on the dopaminergic activity of Cimicifuga racemoza. In: 23rd International LOF-Symposium on Phyto-Oestrogens. Gent, 1999.
  12. Marcus R. Skeletal effects of growth hormone and IGF-I in adults. Horm. Res. 1997; 48(Suppl 5): 60–4.
  13. Mijatovic V., Kenemans P., Netelenbos C. et al. Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil. Steril. 1998; 69(5): 876–82.
  14. Heikkinen J.E., Vaheri R.T., Ahomäki S.M. et al. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens. Am. J. Obstet. Gynecol. 2000; 182(3): 560–7.
  15. Fletcher C.D., Bulpitt C.J. Measurement of quality of life in ceinical trials therapy. Cardiology. 1987; (75, Suppl. 1): 44–52.
  16. Rosen C.J., Conover C. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium. J. Clin. Endocrinol. Metab. 1997; 82(12): 3919–22.
  17. Samsioe G. Medical and surgical strategies for treating urogynecological disorders. Int. J. Fertil. 1996; 41(2): 136–41.
  18. Voropaev A.A., Rudolf Sh. Transcranial electrostimulator (versions) and device for fastening transcranial electrostimulator electrodes. Patent RF N 2397253. 2003. (In Russ.)
  19. Voropaev A.A., Mochalov A.D. The use of transcranial electrostimulation in chronic cerebrovascular insufficiency. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2006; 106(5): 31–4. (In Russ.)
  20. Voropaev A.A., Mochalov A.D., Kornakov G.N. The method of craniospinal electrotherapy and device for its implementation. Patent RF N 2264234. 2004. (In Russ.)
  21. Voropaev A.A., Mochalov A.D., Zhirnova E.V. A method for the treatment of vascular headaches. Patent RF N 2233677. 2002. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies